bibliographic entry 2492532 [be/2492532]
https://w3id.org/oc/corpus/be/2492532

is a

• bibliographic reference

content

• Roden, M, Weng, J, Eilbracht, J. Empagliflozin monotherapy with sitagliptin as an active comparator in patients with type 2 diabetes: a randomised, double-blind, placebo-controlled, phase 3 trial, Lancet Diabetes Endocrinol, 2013, 1, 3, 208, 219, PMID: 24622369

references

• https://w3id.org/oc/corpus/br/1365071